Inclusion criteria for the study included a history
of previous CDI, confirmed by C. difficile fecal toxin immunoassay, new
onset of symptoms after completing a full
course of medication for CDI, positive C. difficile toxin assay confirming recurrent CDI, and age 18 years or older.